Results 241 to 250 of about 781,343 (307)

The prevalence of interstitial lung disease and bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Baekdal JA, Janns LK, Hansen ESH, Meteran H, Bendstrup E, Ulrik CS.   +5 more
europepmc   +1 more source

Connecting sugar and fibrosis: Diabetes as a hidden player in rheumatoid arthritis-associated interstitial lung disease. [PDF]

World J Clin Cases
Lopes LCP.
europepmc   +1 more source

Interstitial Lung Disease: A Review.

JAMA
Importance Interstitial lung disease (ILD) consists of a group of pulmonary disorders characterized by inflammation and/or fibrosis of the lung parenchyma associated with progressive dyspnea that frequently results in end-stage respiratory failure.
Toby M. Maher
semanticscholar   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Interstitial lung diseases

The Lancet, 2022
Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised. Most interstitial lung diseases are characterised by inflammation or fibrosis within the interstitial space, the primary consequence of which is impaired gas exchange, resulting in breathlessness, diminished exercise tolerance, and decreased quality of life ...
Marlies, Wijsenbeek, Atsushi, Suzuki, Toby M, Maher   +2 more
openaire   +2 more sources

Drug-induced interstitial lung disease

European Respiratory Journal, 2022
Interstitial lung disease (ILD) secondary to drug-induced lung injury is an increasingly common cause of morbidity and mortality. The number of drugs associated with the development of ILD continues to rise, mainly due to the use of novel monoclonal ...
P. Spagnolo, P. Bonniaud, G. Rossi, N. Sverzellati, V. Cottin   +4 more
semanticscholar   +1 more source

Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review.

JAMA Oncology, 2021
Importance In the past decade, ERBB2 (formerly HER2)-directed antibody-drug conjugates (ADCs) have substantially changed treatment of both advanced and early-stage ERBB2-positive breast cancer. Novel conjugates are now showing activity in trials of other
P. Tarantino, S. Modi, S. Tolaney, J. Cortés, E. Hamilton, Sung-Bae Kim, Masazaku Toi, F. André, G. Curigliano   +8 more
semanticscholar   +1 more source

Childhood Interstitial Lung Disease

Pediatric Allergy, Immunology, and Pulmonology, 2023
Childhood interstitial lung disease (chILD) is a heterogeneous group of diseases with various clinical and imaging findings. The incidence and prevalence have increased in recent years, probably due to better comprehension of these rare diseases and increased awareness among physicians.
Halime, Nayir Buyuksahin, Nural, Kiper
openaire   +2 more sources